SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Weiguang Zeng, Amabel C.L. Tan, Kylie Horrocks, David C. Jackson, A lipidated form of the extracellular domain of influenza M2 protein as a self-adjuvanting vaccine candidate, Vaccine, 2015, 33, 30, 3526

    CrossRef

  2. 2
    Brendon Y Chua, Lorena E Brown, David C Jackson, Considerations for the rapid deployment of vaccines against H7N9 influenza, Expert Review of Vaccines, 2014, 13, 11, 1327

    CrossRef

  3. 3
    C. Keijzer, B.J. Haijema, T. Meijerhof, P. Voorn, A. de Haan, K. Leenhouts, M.L. van Roosmalen, W. van Eden, F. Broere, Inactivated influenza vaccine adjuvanted with Bacterium-like particles induce systemic and mucosal influenza A virus specific T-cell and B-cell responses after nasal administration in a TLR2 dependent fashion, Vaccine, 2014, 32, 24, 2904

    CrossRef

  4. 4
    Amabel C L Tan, Georgia Deliyannis, Mandvi Bharadwaj, Lorena E Brown, Weiguang Zeng, David C Jackson, The design and proof of concept for a CD8+ T cell-based vaccine inducing cross-subtype protection against influenza A virus, Immunology and Cell Biology, 2013, 91, 1, 96

    CrossRef

  5. 5
    Jodie McVernon, Terry Nolan, Panvax®: a monovalent inactivated unadjuvanted vaccine against pandemic influenza A (H1N1) 2009, Expert Review of Vaccines, 2011, 10, 1, 35

    CrossRef

  6. 6
    Lorena E. Brown, The role of adjuvants in vaccines for seasonal and pandemic influenza, Vaccine, 2010, 28, 50, 8043

    CrossRef

  7. You have full text access to this Open Access content7
    Alan W. Hampson, The ‘novel’ influenza A(H1N1) enigma: is it a pandemic, how should we respond, what should we call it?, Influenza and Other Respiratory Viruses, 2009, 3, 4